Medico-legal implications of sleep apnoea syndrome: Driving license regulations in Europe

Research output: Contribution to journalJournal articleResearchpeer-review

  • A. Alonderis
  • F. Barbee
  • M. Bonsignore
  • P. Calverley
  • W. De Backer
  • K. Diefenbach
  • V. Donic
  • F. Fanfulla
  • I. Fietze
  • K. Franklin
  • L. Grote
  • J. Hedner
  • J. Krieger
  • P. Levy
  • W. McNicholas
  • J. Montserrat
  • G. Parati
  • M. Pascu
  • T. Penzel
  • R. Riha
  • D. Rodenstein
  • A. Sanna
  • R. Schulz
  • E. Sforza
  • P. Sliwinski
  • Z. Tomori
  • P. Tonnesen
  • G. Varoneckas
  • J. Zielinski
  • K. Kostelidou
Background: Sleep apnoea syndrome (SAS), one of the main medical causes of excessive daytime sleepiness, has been shown to be a risk factor for traffic accidents. Treating SAS results in a normalized rate of traffic accidents. As part of the COST Action B-26, we looked at driving license regulations, and especially at its medical aspects in the European region. Methods: We obtained data from Transport Authorities in 25 countries (Austria, AT; Belgium, BE; Czech Republic, CZ; Denmark, DK; Estonia, EE; Finland, FI; France, FR; Germany, DE; Greece, GR; Hungary, HU; Ireland, IE; Italy, IT; Lithuania, LT; Luxembourg, LU; Malta, MT; Netherlands, NL; Norway, EC; Poland, PL; Portugal, PT; Slovakia, SK; Slovenia, SI; Spain, ES; Sweden, SE; Switzerland, CH; United Kingdom, UK). Results: Driving license regulations date from 1997 onwards. Excessive daytime sleepiness is mentioned in nine, whereas sleep apnoea syndrome is mentioned in 10 countries. A patient with untreated sleep apnoea is always considered unfit to drive. To recover the driving capacity, seven countries rely on a physician's medical certificate based on symptom control and compliance with therapy, whereas in two countries it is up to the patient to decide (on his doctor's advice) to drive again. Only FR requires a normalized electroencephalography (EEG)-based Maintenance of Wakefulness Test for professional drivers. Rare conditions (e.g., narcolepsy) are considered a driving safety risk more frequently than sleep apnoea syndrome. Conclusion: Despite the available scientific evidence, most countries in Europe do not include sleep apnoea syndrome or excessive daytime sleepiness among the specific medical conditions to be considered when judging whether or not a person is fit to drive. A unified European Directive seems desirable. (C) 2007 Elsevier B.V. All rights reserved
Udgivelsesdato: 2008/5
Original languageEnglish
JournalSleep Medicine
Issue number4
Pages (from-to)362-375
Number of pages13
Publication statusPublished - 2008

ID: 13834176